🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06155552
Starting soon Observational

Evaluating the Occurrence of Participation Trends Among Weight Loss Clinical Trials Patients

NCT06155552 · tracked via the Priya Life Science USA tracker
Sponsor
Power Life Sciences Inc.
Phase
Observational
Started
2024-12
Last updated
2023-12-04

Condition(s) studied

Weight Loss

Study summary

Clinical studies, with a distinct focus on weight loss, play a crucial role in evaluating the safety and effectiveness of novel treatments. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption.

The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Interested in losing weight and not enrolled in a formal weight loss program or taking medications or supplements that may cause weight change * Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study. * Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed Exclusion Criteria: * Enrolled in another research study * Inability to provide written informed consent * Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Power Life Sciences San Francisco California

More Power Life Sciences Inc. trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06155552 on ClinicalTrials.gov ↗ ← All trials in the USA